Pfizer (PFE) Change in Acquisitions & Divestments (2010 - 2026)

Pfizer has disclosed Change in Acquisitions & Divestments across 17 years of filings, most recently posting $4.6 billion for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 15.7% year-over-year to $4.6 billion; the TTM figure through Mar 2026 stood at $18.6 billion (up 123.94% YoY), while the FY2025 annual figure was $18.0 billion, up 335.05% from the prior year.
• Change in Acquisitions & Divestments eased to $4.6 billion in Q1 2026, from $4.7 billion in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for PFE reached as high as $35.1 billion in Q4 2022 and fell as low as $658.0 million in Q1 2024.
• The 5-year median for Change in Acquisitions & Divestments is $5.4 billion (2023), against an average of $8.1 billion.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments sank 89.72% — and 2025, when it jumped 520.97%.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $35.1 billion in 2022, then plunged by 39.45% to $21.2 billion in 2023, then plunged by 87.62% to $2.6 billion in 2024, then jumped by 79.58% to $4.7 billion in 2025, then dropped by 3.11% to $4.6 billion in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $4.6 billion, $4.7 billion, and $2.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.